ClinGen expert panel — Platelet Disorders VCEP
Benign for Glanzmann thrombasthenia. Applied ACMG criteria (verbatim):
BP7 BP4 BA1
Curation rationale (ClinGen, verbatim)
After a comprehensive literature search of the synonymous variant NM_000212.3(ITGB3):c.882T>C (p.Pro294=), no individuals with Glanzmann thrombasthenia were reported with the variant. Moreover, the variant has a minor allele frequency of 0.2463 (4912/19940 alleles) in gnomAD, found in the East Asian population, which is considerably higher than the expected frequency of the disease (BA1). In Silico predictor spliceAI revealed that the synonymous mutation is not expected to impact splicing at a nucleotide site that is not highly conserved. In conclusion the criteria BA1, BP4, and BP7 were applied to reach a classification of benign.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 0.43 | GERP -1.7, phastCons 0.99 |
| Overall | ||
| CADD | 12.22 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 22.3% | 4 |
| Middle Eastern | 17.4% | 6 |
| South Asian | 16% | 6 |
| African / African-American | 15.7% | 6 |
| Amishnot grpmax-eligible | 14.6% | 7 |
| Ashkenazi Jewishnot grpmax-eligible | 13.9% | 7 |
| Remaining individualsnot grpmax-eligible | 9.99% | 10 |
| Admixed American | 6.81% | 15 |
| European (non-Finnish) | 6.67% | 15 |
| Finnishnot grpmax-eligible | 4.06% | 25 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ITGB3
- Protein
- p.Pro294=
- Coding
- c.882T>C
- MANE Select
- NM_000212
- dbSNP
- rs5919
- Type
- single nucleotide variant
- Location
- chr17:47287174 (GRCh38)
- Gene constraint
- LOEUF 0.685 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 87.19 · 125 PDB
- Residue 294
- the 'cx3cl1-binding' region; an α-helix; the vwfa domain
Disease context
Glanzmann thrombasthenia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Glanzmann thrombasthenia (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- ITGB3 c.166-2A>G Pathogenic ★★★ same condition
- ITGB3 c.1913+1G>A Pathogenic ★★★ same condition
- ITGB3 c.1913+5G>T Likely pathogenic ★★★ same condition
- ITGB3 c.2014+1G>A Pathogenic ★★★ same condition
- ITGB3 c.2014+5G>A Likely pathogenic ★★★ same condition
- ITGB3 c.2301+1G>C Pathogenic ★★★ same condition
- ITGB3 c.361+1G>A Pathogenic ★★★ same condition
- ITGB3 c.362-1G>A Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/itgb3-p-pro294 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown